{"meta":{"query_hash":"cbefac99ba71","filters":{"venue":"Cancer Communications"},"cohort_total":24,"direct_labels_cover":0,"predictions_cover":24,"exported":24,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/cbefac99ba71","api":"https://metacan.xera.ac/api/v1/cohort?venue=Cancer+Communications"},"results":[{"id":"W2978677248","doi":"10.1186/s40880-019-0397-1","title":"A novel prognostic prediction tool for postoperative recurrence in patients with stage II/III colon cancer","year":2019,"lang":"en","type":"letter","venue":"Cancer Communications","topic":"Circular RNAs in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Colorectal cancer; Stage (stratigraphy); Disease; Cancer; Oncology; Medicine; Internal medicine; Adjuvant; Bioinformatics; Adjuvant chemotherapy; Biomarker; Adjuvant therapy; Biology","score_opus":0.02352228968308826,"score_gpt":0.29569361773845937,"score_spread":0.2721713280553711,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978677248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.65795416,0.023649355,0.003763522,0.22723505,0.0020426286,0.021515353,0.06280428,0.00012414154,0.00091152324],"genre_scores_gemma":[0.6648464,0.0053361426,0.0036992438,0.21448606,0.001588865,0.031930286,0.06934871,0.00035172372,0.008412567],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99874246,0.0000773587,0.0002754922,0.00046680294,0.00017002698,0.0002678575],"domain_scores_gemma":[0.9976194,0.000065644505,0.00023229286,0.0015941786,0.00046090296,0.000027614766],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00006805732,0.00025461474,0.00024748305,0.00007161155,0.00019812839,0.00003334431,0.0008104664,0.00035088722,0.000026145592],"category_scores_gemma":[0.00012749806,0.0002490909,0.000079721,0.0001445559,0.00017528553,0.000011666264,0.00034503586,0.0005016398,0.0000016763597],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005878207,0.0009205871,0.23278885,0.00042214576,0.0006412104,0.0000010169538,0.00049181667,0.0009797427,0.005639692,0.000038196067,0.75441784,0.0030710706],"study_design_scores_gemma":[0.0026821468,0.00050475646,0.032204345,0.0005864702,0.00017282601,6.3558747e-7,0.000020994674,0.00018607762,0.00045987035,0.0000048180623,0.96269244,0.00048461693],"about_ca_topic_score_codex":0.00023250742,"about_ca_topic_score_gemma":0.0008855618,"teacher_disagreement_score":0.20827459,"about_ca_system_score_codex":0.00023432824,"about_ca_system_score_gemma":0.0007532941,"threshold_uncertainty_score":0.9999961},"labels":[],"label_agreement":null},{"id":"W2979711603","doi":"10.1186/s40880-019-0405-5","title":"Comparison of efficacy and safety among axitinib, sunitinib, and sorafenib as neoadjuvant therapy for renal cell carcinoma: a retrospective study","year":2019,"lang":"en","type":"letter","venue":"Cancer Communications","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Institutes of Health Research","funders":"Renji Hospital; Science and Technology Commission of Shanghai Municipality; Pfizer","keywords":"Sunitinib; Sorafenib; Axitinib; Medicine; Renal cell carcinoma; Oncology; Targeted therapy; Internal medicine; Neoadjuvant therapy; Radiation therapy; Tyrosine-kinase inhibitor; Cancer; Breast cancer; Hepatocellular carcinoma","score_opus":0.08029438110833828,"score_gpt":0.3685204662015316,"score_spread":0.28822608509319336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979711603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91009724,0.024001794,0.000013970627,0.05445262,0.000115340394,0.0071164323,0.0005144417,0.000047712303,0.0036404599],"genre_scores_gemma":[0.9847983,0.0025938957,0.00057216536,0.008177374,0.00032763876,0.0009762883,0.0009465979,0.00010975027,0.0014979653],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975689,0.0003197706,0.0007693729,0.0006184325,0.00036334284,0.00036015685],"domain_scores_gemma":[0.9952698,0.000907176,0.0006706929,0.002534794,0.0005063027,0.00011128379],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024824298,0.0004852189,0.0014041879,0.00022817994,0.0003006314,0.000040756095,0.0005145619,0.00038464458,0.00005860157],"category_scores_gemma":[0.000059580005,0.0004255182,0.0001838808,0.00020480475,0.0005753064,0.00006427999,0.00032352665,0.0013959381,0.0000043285313],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025523661,0.0035166647,0.8086506,0.0010283409,0.0016391326,0.000058791153,0.01667221,0.000008909942,0.0015064985,0.00008566929,0.15705046,0.007230339],"study_design_scores_gemma":[0.018346159,0.0062135663,0.82668656,0.0005474722,0.0017338854,0.000026902102,0.0020005296,0.00014444243,0.0017656507,0.00005538919,0.14185189,0.0006275426],"about_ca_topic_score_codex":0.0013596065,"about_ca_topic_score_gemma":0.00019094849,"teacher_disagreement_score":0.07470109,"about_ca_system_score_codex":0.00034774517,"about_ca_system_score_gemma":0.00040263156,"threshold_uncertainty_score":0.99981964},"labels":[],"label_agreement":null},{"id":"W2981537896","doi":"10.1186/s40880-019-0398-0","title":"Optimal sequencing of chemotherapy with chemoradiotherapy based on TNM stage classification and EBV DNA in locoregionally advanced nasopharyngeal carcinoma","year":2019,"lang":"en","type":"letter","venue":"Cancer Communications","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Natural Science Foundation of China; Varian Medical Systems; Sanofi; National Key Research and Development Program of China; AstraZeneca","keywords":"Nasopharyngeal carcinoma; Stage (stratigraphy); Chemoradiotherapy; Oncology; DNA sequencing; Chemotherapy; Medicine; Internal medicine; DNA; Biology; Radiation therapy; Genetics","score_opus":0.05932965691010148,"score_gpt":0.32464803823942145,"score_spread":0.26531838132931995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981537896","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22564407,0.009301923,0.00014069334,0.75651085,0.00012504411,0.002439002,0.00033614485,0.00007921519,0.00542308],"genre_scores_gemma":[0.6239938,0.013400084,0.009620923,0.34811515,0.0004562945,0.0012125204,0.0008699386,0.00019933605,0.0021319243],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99838513,0.000101162586,0.00042283972,0.0004537736,0.0003457239,0.00029134806],"domain_scores_gemma":[0.99724907,0.00032003297,0.00035228004,0.0017956574,0.00023012758,0.000052860913],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013746796,0.00034869762,0.00089947134,0.0002730235,0.000099798875,0.000014094421,0.00042571613,0.00029090734,0.00005896418],"category_scores_gemma":[0.000015768619,0.00030430095,0.000088774934,0.00033660315,0.0004187986,0.000074721946,0.00004601299,0.001116325,0.0000021341893],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012565363,0.002017281,0.35044298,0.012113284,0.0023973,0.00031104687,0.01713882,0.0048860507,0.071933895,0.0009080093,0.44484928,0.0804367],"study_design_scores_gemma":[0.018899899,0.0023986837,0.18064016,0.005893317,0.00028525674,0.000026809877,0.00074017874,0.024312064,0.0029115565,0.0000130905755,0.76261246,0.0012665516],"about_ca_topic_score_codex":0.00025837144,"about_ca_topic_score_gemma":0.00017609553,"teacher_disagreement_score":0.40839568,"about_ca_system_score_codex":0.00083214947,"about_ca_system_score_gemma":0.0012470636,"threshold_uncertainty_score":0.99994093},"labels":[],"label_agreement":null},{"id":"W3092210493","doi":"10.1002/cac2.12101","title":"The prognostic significance of non‐sentinel lymph node metastasis in cutaneous and acral melanoma patients—A multicenter retrospective study","year":2020,"lang":"en","type":"article","venue":"Cancer Communications","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brandon Regional Health Authority","funders":"National Natural Science Foundation of China","keywords":"Medicine; Sentinel lymph node; Melanoma; Internal medicine; Oncology; Adjuvant therapy; Proportional hazards model; Retrospective cohort study; Stage (stratigraphy); Lymphovascular invasion; Cancer; Metastasis; Surgery; Breast cancer","score_opus":0.027369894316273815,"score_gpt":0.29415995583142085,"score_spread":0.26679006151514706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092210493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914097,0.0005558043,0.00007853698,0.004975581,0.00006766153,0.0015922883,0.000029747254,0.000032932272,0.0012577561],"genre_scores_gemma":[0.99815965,0.0005966611,0.00033731482,0.0003780162,0.00002193323,0.00034390335,0.000010183555,0.000016999864,0.00013532068],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99899894,0.00011825886,0.0003337463,0.00021395723,0.00017950701,0.00015556504],"domain_scores_gemma":[0.998747,0.00014707023,0.00014787023,0.0007070811,0.00016593619,0.000085038555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009471254,0.000119210454,0.00024511068,0.000052079242,0.00016986934,0.000023562487,0.00028702346,0.000025619802,0.000027277934],"category_scores_gemma":[0.00020681179,0.00009412401,0.000048049147,0.000309925,0.00015931412,0.000036017136,0.0002750349,0.00017608514,0.0000063433176],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020889912,0.00058201794,0.99169916,0.00004549131,0.00017352513,0.000009626762,0.0023322664,0.000020935055,0.0004903241,0.00003630274,0.00012122874,0.004280207],"study_design_scores_gemma":[0.0021514595,0.00020248571,0.9880672,0.0000555731,0.00025209048,0.000005999133,0.0029041683,0.00417246,0.00011187008,0.000010594051,0.0019582026,0.000107903565],"about_ca_topic_score_codex":0.00032808655,"about_ca_topic_score_gemma":0.00037922413,"teacher_disagreement_score":0.006749975,"about_ca_system_score_codex":0.00013242432,"about_ca_system_score_gemma":0.00004885179,"threshold_uncertainty_score":0.38382655},"labels":[],"label_agreement":null},{"id":"W3119084223","doi":"10.1002/cac2.12128","title":"Lung adenocarcinoma patients with novel ALK fusion variants and their clinical responses to ALK inhibitors","year":2021,"lang":"en","type":"article","venue":"Cancer Communications","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Crizotinib; Anaplastic lymphoma kinase; Ceritinib; Lung cancer; Medicine; ALK inhibitor; ROS1; Adenocarcinoma; Alectinib; Targeted therapy; Internal medicine; Oncology; Cancer research; Pathology; Cancer; Malignant pleural effusion","score_opus":0.04499332222414623,"score_gpt":0.37927840711824706,"score_spread":0.3342850848941008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3119084223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9688347,0.007175147,0.00084739795,0.01799539,0.00024524893,0.00089198735,0.0004515004,0.000068034584,0.0034905677],"genre_scores_gemma":[0.9903066,0.0011004157,0.0052766586,0.0017758486,0.00007820554,0.00022088227,0.00023865435,0.000028463945,0.0009742313],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99899554,0.000102496866,0.00030085625,0.0002946548,0.00013450222,0.00017197104],"domain_scores_gemma":[0.9977634,0.00027379303,0.00008660478,0.001241947,0.0004047912,0.00022944389],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010661004,0.00014536334,0.000251337,0.00007452358,0.00031425996,0.000034355544,0.00016705987,0.00006813619,0.000066329594],"category_scores_gemma":[0.00013321091,0.0001078465,0.000054520035,0.0003427532,0.0001622911,0.0000936459,0.00026970106,0.00019446618,0.000006207174],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027629055,0.00090382947,0.97142315,0.000027535678,0.00036257744,0.0000049750684,0.0019575544,0.000004440233,0.00050411857,0.00043338008,0.0028730556,0.02122909],"study_design_scores_gemma":[0.0031103129,0.00021784063,0.9517696,0.00030427327,0.00031446002,0.000012055837,0.00050239335,0.00010769797,0.00017509527,0.00002230136,0.04332166,0.00014231184],"about_ca_topic_score_codex":0.00016221816,"about_ca_topic_score_gemma":0.0003410239,"teacher_disagreement_score":0.040448606,"about_ca_system_score_codex":0.00016602632,"about_ca_system_score_gemma":0.0006166318,"threshold_uncertainty_score":0.43978524},"labels":[],"label_agreement":null},{"id":"W3133444826","doi":"10.1002/cac2.12151","title":"An integrated genetic‐epigenetic analysis shed light on the mechanisms linking coronavirus disease 2019 (COVID‐19) and cancer","year":2021,"lang":"en","type":"letter","venue":"Cancer Communications","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; Genome British Columbia; University of British Columbia","funders":"","keywords":"Biostatistics; Library science; Columbia university; Epidemiology; Medicine; History; Geography; Sociology; Media studies; Pathology","score_opus":0.1737411189530755,"score_gpt":0.4479511603154512,"score_spread":0.2742100413623757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133444826","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017597235,0.06323739,0.0023497893,0.9299974,0.0002385211,0.0010294878,0.0011795659,0.00010965447,0.000098453194],"genre_scores_gemma":[0.07766333,0.075063854,0.00089876004,0.8396934,0.00080534664,0.0009923215,0.0034609896,0.000105081424,0.0013168793],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997024,0.00077313586,0.00054299034,0.0006895161,0.000479525,0.00049084635],"domain_scores_gemma":[0.9928892,0.00071314967,0.00032854354,0.004909841,0.00042861883,0.00073064456],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002718353,0.00045309542,0.0007614409,0.00041798726,0.00076790847,0.00015568965,0.0010671652,0.0004740862,0.0013125921],"category_scores_gemma":[0.00026087364,0.00034181867,0.00028380434,0.0011382357,0.0002446833,0.000049986786,0.00028712535,0.0022428478,0.000014589881],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008778802,0.0012753804,0.053435747,0.0042828303,0.0149108935,0.0011337299,0.012137003,0.003625519,0.0027678504,0.0022043567,0.60059464,0.30275416],"study_design_scores_gemma":[0.0004621996,0.00011268359,0.031851668,0.00074512523,0.0048018363,0.0000051574402,0.00013414369,0.002613287,0.00004887867,0.0004414502,0.9583493,0.0004343125],"about_ca_topic_score_codex":0.015911255,"about_ca_topic_score_gemma":0.014364071,"teacher_disagreement_score":0.3577546,"about_ca_system_score_codex":0.0011613667,"about_ca_system_score_gemma":0.004969399,"threshold_uncertainty_score":0.9999034},"labels":[],"label_agreement":null},{"id":"W3199261654","doi":"10.1002/cac2.12205","title":"Novel strategy for disease risk prediction incorporating predicted gene expression and DNA methylation data: a multi‐phased study of prostate cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Communications","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; National Cancer Institute; National Institute on Aging; Swedish Cancer Foundation; Medical Research Council; Canadian Institutes of Health Research; Ovarian Cancer Research Fund; National Institutes of Health; National Heart, Lung, and Blood Institute; Vetenskapsrådet; National Health and Medical Research Council; Cancer Research UK; Wellcome Trust; European Commission; Breast Cancer Research Foundation; U.S. Department of Defense","keywords":"DNA methylation; Prostate cancer; Computational biology; Biobank; Bioinformatics; Computer science; Oncology; Medicine; Biology; Cancer; Internal medicine; Gene; Gene expression; Genetics","score_opus":0.09813911593421933,"score_gpt":0.3754635667036976,"score_spread":0.2773244507694783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199261654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92549247,0.015118279,0.053148426,0.00009766092,0.00007681948,0.0008842071,0.005157365,0.000013902918,0.000010858419],"genre_scores_gemma":[0.9760715,0.0062293005,0.012933272,0.00000937694,0.00007594482,0.0005765248,0.004039766,0.000021175312,0.00004314057],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989067,0.00016632461,0.00034791292,0.00036959915,0.00010594152,0.00010357508],"domain_scores_gemma":[0.9977268,0.000053402506,0.0003354399,0.0013687062,0.00043535364,0.00008031403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002542915,0.000114651375,0.0001326635,0.000035565135,0.00025801559,0.000028580247,0.0002720234,0.00006914599,0.000002889406],"category_scores_gemma":[0.00019690258,0.00011800327,0.000027031181,0.00014133473,0.00006995581,0.000021283275,0.00029518455,0.00008464894,4.2336506e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008744931,0.00047650933,0.05157971,0.000039753544,0.00007878984,8.028337e-8,0.0002692527,0.0037374797,0.9373682,0.000005017114,0.000020191748,0.0063375626],"study_design_scores_gemma":[0.0055272817,0.0004050984,0.18694828,0.00012005336,0.0004920212,4.3125917e-7,0.001138846,0.07440856,0.7282852,0.00016792823,0.0021881266,0.00031819305],"about_ca_topic_score_codex":0.0002460729,"about_ca_topic_score_gemma":0.0011419611,"teacher_disagreement_score":0.20908304,"about_ca_system_score_codex":0.000020597865,"about_ca_system_score_gemma":0.00028760693,"threshold_uncertainty_score":0.48120338},"labels":[],"label_agreement":null},{"id":"W3207609899","doi":"10.1002/cac2.12223","title":"Licochalcone A suppresses Sp1 expression with potential anti‐myeloma activity","year":2021,"lang":"en","type":"letter","venue":"Cancer Communications","topic":"Pharmacological Effects of Natural Compounds","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Natural Science Foundation of China","keywords":"Multiple myeloma; Cancer research; Expression (computer science); Chemistry; Biology; Medicine; Internal medicine; Computer science","score_opus":0.18194061755284416,"score_gpt":0.46442200016496105,"score_spread":0.28248138261211686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207609899","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07643395,0.021165509,0.00013959297,0.88986063,0.002499372,0.0015525686,0.0010945649,0.0005501618,0.006703676],"genre_scores_gemma":[0.6299981,0.007790396,0.00079055416,0.35316607,0.0027176822,0.0011547535,0.0012760051,0.00012130848,0.0029851394],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949186,0.0025656808,0.00042294027,0.00080868293,0.0004333125,0.00085078774],"domain_scores_gemma":[0.9946699,0.0018601632,0.00051907,0.0022128082,0.00048340487,0.00025464094],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00031336927,0.00069683656,0.0009012238,0.00019711746,0.001015644,0.00012573959,0.0028909927,0.0019514435,0.003773911],"category_scores_gemma":[0.00009516729,0.00058761373,0.00029388376,0.0005301348,0.0010173072,0.0003138503,0.0015907703,0.010429879,0.00009839335],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002044986,0.00037391574,0.00017826988,0.00024626756,0.0005864112,0.00048721637,0.000071718074,0.00022500783,0.19697613,0.000015295622,0.79535174,0.0052835247],"study_design_scores_gemma":[0.0014173576,0.00012508495,0.0006709687,0.00024885408,0.0007564396,0.0001006556,0.00002113438,0.00069638266,0.06245869,0.00006383971,0.93267864,0.0007619528],"about_ca_topic_score_codex":0.000102034704,"about_ca_topic_score_gemma":0.00007126731,"teacher_disagreement_score":0.55356413,"about_ca_system_score_codex":0.0003298202,"about_ca_system_score_gemma":0.00052736787,"threshold_uncertainty_score":0.9996575},"labels":[],"label_agreement":null},{"id":"W3208045032","doi":"10.1002/cac2.12218","title":"The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma","year":2021,"lang":"en","type":"article","venue":"Cancer Communications","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":401,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Nasopharyngeal carcinoma; Medicine; Clinical Oncology; Internal medicine; Oncology; Incidence (geometry); Medical physics; Intensive care medicine; Radiation therapy; Cancer","score_opus":0.4629509190193338,"score_gpt":0.5729864008573355,"score_spread":0.11003548183800177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3208045032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4552868,0.29486793,0.00004104206,0.24748191,0.0005100695,0.00081231416,0.00014998912,0.000013215594,0.0008367273],"genre_scores_gemma":[0.5388995,0.45519376,0.0034756956,0.001155559,0.00030700004,0.0006866923,0.000013762969,0.000008688786,0.0002593422],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984654,0.00019594905,0.00096303684,0.00016023227,0.000092652546,0.00012271474],"domain_scores_gemma":[0.9898243,0.0077595157,0.00026783216,0.0011817919,0.0008987881,0.00006774845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070452935,0.00009930283,0.0006520771,0.0000074371533,0.00034616402,0.0000047000776,0.0002434228,0.00008874028,0.000013828453],"category_scores_gemma":[0.001085602,0.00004959794,0.00042472896,0.00014710447,0.0009398438,0.000017919663,0.0002019467,0.00014007553,3.6338827e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013698236,0.00051113893,0.6024754,0.00003462456,0.0006378973,3.6848556e-7,0.0007850295,0.0000011096098,0.00002642899,0.00023995347,0.024170257,0.37098083],"study_design_scores_gemma":[0.0025263464,0.00080303225,0.55049396,0.000057822144,0.00044019255,0.0000032061314,0.0010656653,0.0010662859,0.000119364224,0.0000745679,0.44330275,0.00004680846],"about_ca_topic_score_codex":0.0004194211,"about_ca_topic_score_gemma":0.0026608852,"teacher_disagreement_score":0.4191325,"about_ca_system_score_codex":0.000058276677,"about_ca_system_score_gemma":0.00092486036,"threshold_uncertainty_score":0.3462894},"labels":[],"label_agreement":null},{"id":"W3214235689","doi":"10.1002/cac2.12236","title":"Detection of pancreatic cancer by indocyanine green‐assisted fluorescence imaging in the first and second near‐infrared windows","year":2021,"lang":"en","type":"letter","venue":"Cancer Communications","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"National Institute on Alcohol Abuse and Alcoholism; National Institutes of Health","keywords":"Indocyanine green; Pancreatic cancer; Infrared; Fluorescence; Fluorescence-lifetime imaging microscopy; Medicine; Nuclear medicine; Cancer; Chemistry; Pathology; Optics; Internal medicine; Physics","score_opus":0.01768173778084683,"score_gpt":0.23741186773626835,"score_spread":0.21973012995542152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214235689","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07813386,0.5296486,0.0012568127,0.36867228,0.002733384,0.005247145,0.0077252015,0.00076697266,0.0058157262],"genre_scores_gemma":[0.79992825,0.07748468,0.0019359218,0.108616315,0.0012910742,0.005750058,0.0024249575,0.00061862584,0.0019501096],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99859506,0.00007968411,0.000522274,0.00024585018,0.00023370121,0.00032340843],"domain_scores_gemma":[0.9975765,0.0003745938,0.00019130802,0.0017032624,0.000120592995,0.00003375193],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012394824,0.00032297042,0.00044194006,0.00012601171,0.00022103766,0.00010191645,0.0010751694,0.00026179195,0.00012528824],"category_scores_gemma":[0.000024135563,0.00030352556,0.00008412473,0.0005928047,0.0003071599,0.00018906045,0.0001650854,0.0015040274,0.0000022394145],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048650665,0.00011945082,0.012428856,0.0044062547,0.0009921592,0.00006417629,0.009078455,0.00096406305,0.118781455,0.000014887631,0.75498766,0.09811393],"study_design_scores_gemma":[0.0008212971,0.000016117156,0.0042019864,0.0010790277,0.00024446205,0.000025739952,0.00019402431,0.00973366,0.0038788966,0.00007028623,0.9792007,0.0005337599],"about_ca_topic_score_codex":0.0022354184,"about_ca_topic_score_gemma":0.009617197,"teacher_disagreement_score":0.7217944,"about_ca_system_score_codex":0.00043375464,"about_ca_system_score_gemma":0.00015008423,"threshold_uncertainty_score":0.9999417},"labels":[],"label_agreement":null},{"id":"W4281746720","doi":"10.1002/cac2.12314","title":"Cancer diagnosis is one quarter lower than the expected cancer incidence in the first year of COVID‐19 pandemic in Germany: A retrospective register‐based cohort study","year":2022,"lang":"en","type":"letter","venue":"Cancer Communications","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Association of University Research Administrators","funders":"Deutsche Forschungsgemeinschaft","keywords":"Coronavirus disease 2019 (COVID-19); Pandemic; Retrospective cohort study; Incidence (geometry); Quarter (Canadian coin); Cancer; Medicine; 2019-20 coronavirus outbreak; Cohort; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Register (sociolinguistics); Cancer incidence; Internal medicine; Virology; Disease; History; Mathematics","score_opus":0.15244275992520911,"score_gpt":0.4369747190569758,"score_spread":0.2845319591317667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281746720","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09763259,0.009637274,0.0000049589844,0.8862976,0.00025164222,0.0049172384,0.0009346121,0.000052515632,0.00027156167],"genre_scores_gemma":[0.6268281,0.011270936,0.000009627453,0.3392278,0.00030739803,0.022007849,0.00010373039,0.000051017814,0.00019353218],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959122,0.0010531473,0.0008887244,0.0006336729,0.0009936313,0.00051865523],"domain_scores_gemma":[0.9923867,0.0019239148,0.00067883637,0.0045893677,0.0003063089,0.00011485123],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010939029,0.0003918724,0.0009524005,0.00041794663,0.00046297885,0.00004247559,0.0021018628,0.00033047577,0.0026010799],"category_scores_gemma":[0.0004075787,0.00029081554,0.00020130089,0.0015989755,0.00047134105,0.00008904735,0.00039066296,0.003853894,0.0000049511923],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014042856,0.00037772386,0.7434195,0.00021945944,0.00015606721,0.000032480795,0.020458,0.000017497132,0.0000017743232,0.000004901413,0.23509265,0.00007946076],"study_design_scores_gemma":[0.0012591638,0.0002322728,0.69470084,0.0007233692,0.00031441002,0.0000032593016,0.002040343,0.00004812927,0.0000012089155,0.0000365876,0.30041382,0.00022658383],"about_ca_topic_score_codex":0.24726139,"about_ca_topic_score_gemma":0.43028754,"teacher_disagreement_score":0.5470698,"about_ca_system_score_codex":0.00592904,"about_ca_system_score_gemma":0.003961005,"threshold_uncertainty_score":0.9999544},"labels":[],"label_agreement":null},{"id":"W4308187251","doi":"10.1002/cac2.12383","title":"Multiplexed imaging of tumor immune microenvironmental markers in locally advanced or metastatic non‐small‐cell lung cancer characterizes the features of response to PD‐1 blockade plus chemotherapy","year":2022,"lang":"en","type":"article","venue":"Cancer Communications","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Emergent BioSolutions (Canada)","funders":"Science and Technology Commission of Shanghai Municipality; Shanghai Pulmonary Hospital; National Natural Science Foundation of China","keywords":"Chemotherapy; Oncology; Lung cancer; Medicine; Immune system; Immunotherapy; Internal medicine; CD68; Predictive marker; PD-L1; CD8; Blockade; Immune checkpoint; Cancer research; Cancer; Immunology; Immunohistochemistry; Receptor","score_opus":0.014554368802750031,"score_gpt":0.2962930912548511,"score_spread":0.2817387224521011,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308187251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95617265,0.028891912,0.000026247393,0.012225431,0.00013201234,0.0020589244,0.00040100885,0.000019598507,0.00007224858],"genre_scores_gemma":[0.9854173,0.0063497177,0.0031830869,0.0020315694,0.000015044418,0.0019874363,0.00004992183,0.00005526919,0.0009106345],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981175,0.00038189476,0.0006638998,0.00027071312,0.00026776223,0.00029820055],"domain_scores_gemma":[0.99755937,0.00040234177,0.0004185732,0.0014902577,0.000061431,0.000067999405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006066286,0.00023225204,0.0005078071,0.0001808131,0.00025658344,0.000012089284,0.0009706606,0.000022425449,0.0006919777],"category_scores_gemma":[0.00003799414,0.00018525567,0.00018196466,0.0006748911,0.00035936563,0.00006374046,0.00038847563,0.0004012643,6.5878356e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03554754,0.00034535993,0.0051792795,0.00012095854,0.00024021936,0.000005969703,0.0048184856,0.00051725394,0.94109094,0.000001122457,0.00038656054,0.0117463125],"study_design_scores_gemma":[0.022287022,0.0006458776,0.659757,0.0010256275,0.00039871078,0.00006461614,0.016043322,0.0031479893,0.2660957,0.0000034046855,0.029956067,0.0005746665],"about_ca_topic_score_codex":0.0029239275,"about_ca_topic_score_gemma":0.00078726717,"teacher_disagreement_score":0.67499524,"about_ca_system_score_codex":0.0009005233,"about_ca_system_score_gemma":0.0007210925,"threshold_uncertainty_score":0.75766706},"labels":[],"label_agreement":null},{"id":"W4317830464","doi":"10.1002/cac2.12401","title":"A nanotherapeutic strategy to target drug‐tolerant cells and overcome EGFR tyrosine kinase inhibitor resistance in lung cancer","year":2023,"lang":"en","type":"letter","venue":"Cancer Communications","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; FujiFilm VisualSonics (Canada)","funders":"National Cancer Institute; National Institutes of Health","keywords":"Cancer research; Epidermal growth factor receptor; Lung cancer; Population; Receptor tyrosine kinase; Drug resistance; AXL receptor tyrosine kinase; Medicine; Cancer; Chemistry; Pharmacology; Biology; Internal medicine; Receptor","score_opus":0.06163173093804817,"score_gpt":0.38704525461997497,"score_spread":0.3254135236819268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317830464","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02126772,0.076618716,0.000032435702,0.8950556,0.0003471112,0.00235993,0.00095724704,0.00011603301,0.0032452072],"genre_scores_gemma":[0.07081818,0.0991107,0.007917574,0.6311876,0.0033175028,0.012415461,0.0011587898,0.0005139682,0.1735602],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99753773,0.00032658826,0.0005862056,0.0005317214,0.00038896585,0.0006287749],"domain_scores_gemma":[0.9968028,0.0006883088,0.00016015615,0.0019299913,0.00022965921,0.0001890629],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034066752,0.0003541159,0.0009682797,0.00043427444,0.00023084333,0.000059880796,0.0006777869,0.00044668987,0.00034709534],"category_scores_gemma":[0.000052888106,0.00033815717,0.00009291467,0.00080068805,0.00040920725,0.00006795357,0.00034135493,0.001997158,0.00004730762],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017427494,0.00013682901,0.012903636,0.0012716455,0.00029260846,0.0002316939,0.0016455251,0.00002182431,0.0021637492,0.00012396525,0.9803194,0.00071484887],"study_design_scores_gemma":[0.0018168958,0.000093553834,0.013926103,0.0032669492,0.0003614525,0.0000069157973,0.00012738162,0.0010167259,0.0001334795,0.00023255503,0.97856146,0.00045649958],"about_ca_topic_score_codex":0.0037669574,"about_ca_topic_score_gemma":0.009685245,"teacher_disagreement_score":0.26386797,"about_ca_system_score_codex":0.0011741966,"about_ca_system_score_gemma":0.0015236518,"threshold_uncertainty_score":0.999907},"labels":[],"label_agreement":null},{"id":"W4379507891","doi":"10.1002/cac2.12447","title":"Predictive power of tertiary lymphoid structure signature for neoadjuvant chemotherapy response and immunotherapy benefit in HER2‐negative breast cancer","year":2023,"lang":"en","type":"letter","venue":"Cancer Communications","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Nautical Research Society","funders":"Ligue Contre le Cancer","keywords":"Oncology; Medicine; Internal medicine; Breast cancer; Pembrolizumab; Cancer; Predictive marker; Immunotherapy; Gene signature; Biology; Gene expression","score_opus":0.015106574438103298,"score_gpt":0.30304266497191407,"score_spread":0.28793609053381075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379507891","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06467249,0.06679438,0.000030135127,0.8416619,0.00063160836,0.0038484975,0.022156905,0.00013508034,0.00006900874],"genre_scores_gemma":[0.21349436,0.18037498,0.001802196,0.5862154,0.0015393941,0.006246928,0.0029654943,0.00082864315,0.0065326295],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99760085,0.00023015785,0.0007470516,0.0006078154,0.00034399444,0.00047012937],"domain_scores_gemma":[0.9961127,0.0008347515,0.00055588054,0.001971722,0.00045471668,0.000070251066],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031723082,0.00054986204,0.00096690847,0.0003860776,0.00018392205,0.000034030367,0.0007647692,0.0010186646,0.0004855844],"category_scores_gemma":[0.000039094073,0.0004896055,0.0003138608,0.0006705408,0.0007405426,0.0001261597,0.00014438959,0.0014376866,9.966967e-7],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05359428,0.0003719262,0.013565227,0.0010521827,0.0052097067,0.000034056586,0.012938023,0.00007696559,0.05098967,0.000017945435,0.7856518,0.076498196],"study_design_scores_gemma":[0.018457573,0.00078339747,0.42242298,0.005819391,0.000491975,0.00013525429,0.0010726779,0.00044992872,0.0037692843,0.00092070835,0.5444308,0.0012460047],"about_ca_topic_score_codex":0.0038698195,"about_ca_topic_score_gemma":0.0017193559,"teacher_disagreement_score":0.40885776,"about_ca_system_score_codex":0.00094805734,"about_ca_system_score_gemma":0.0010347294,"threshold_uncertainty_score":0.99975556},"labels":[],"label_agreement":null},{"id":"W4387930994","doi":"10.1002/cac2.12496","title":"Dynamics and cytokinic regulation of immune cell infiltration in genetically engineered mouse models of pancreatic cancer dictate the sensitivity to immunotherapy","year":2023,"lang":"en","type":"letter","venue":"Cancer Communications","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"","keywords":"Immunophenotyping; Immune system; Cancer research; Biology; KRAS; CD8; Tumor microenvironment; CD80; Immunotherapy; Pancreatic cancer; Flow cytometry; Cancer; Immunology; Cytotoxic T cell; Colorectal cancer","score_opus":0.04858681729706475,"score_gpt":0.3398288874732581,"score_spread":0.29124207017619336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387930994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.53300256,0.007939937,0.004643831,0.4492487,0.00009646173,0.0030675617,0.000832144,0.000058306778,0.0011105217],"genre_scores_gemma":[0.93421185,0.0488004,0.0027432886,0.009588979,0.00014058119,0.0010573409,0.00071726774,0.000092980816,0.0026472937],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9980337,0.00042912207,0.0007483603,0.00022594143,0.00030726765,0.0002556098],"domain_scores_gemma":[0.99641865,0.0011839716,0.00030618944,0.001685655,0.00035774847,0.000047766174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006081274,0.0002052505,0.0007923461,0.00028599935,0.0000877798,0.000010739022,0.00035044437,0.00034388434,0.000026545302],"category_scores_gemma":[0.00009996602,0.00017024516,0.00009661876,0.0005302367,0.00041275434,0.000050761926,0.00018077089,0.00091907417,0.0000023868988],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030751717,0.0019705158,0.1594539,0.010204409,0.006170719,0.00006903503,0.038845677,0.05797493,0.57921106,0.005855629,0.084552005,0.05261698],"study_design_scores_gemma":[0.0031361575,0.00046597497,0.32559133,0.002066114,0.0010980091,0.00001483659,0.00045546258,0.6586974,0.003639493,0.0014025471,0.0028829516,0.0005497253],"about_ca_topic_score_codex":0.005236943,"about_ca_topic_score_gemma":0.0022154455,"teacher_disagreement_score":0.6007225,"about_ca_system_score_codex":0.00035341183,"about_ca_system_score_gemma":0.0006290105,"threshold_uncertainty_score":0.7916726},"labels":[],"label_agreement":null},{"id":"W4393231250","doi":"10.1002/cac2.12540","title":"Immune cell pair ratio captured by imaging mass cytometry has superior predictive value for prognosis of non‐small cell lung cancer than cell fraction and density","year":2024,"lang":"en","type":"letter","venue":"Cancer Communications","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institutes of Health; Cancer Prevention and Research Institute of Texas","keywords":"Mass cytometry; Lung cancer; Predictive value; Immune system; Cell; Flow cytometry; Medicine; Oncology; Pathology; Internal medicine; Chemistry; Immunology; Phenotype","score_opus":0.01658592197096139,"score_gpt":0.2655287443334488,"score_spread":0.2489428223624874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393231250","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011275269,0.8017215,0.01461342,0.14960088,0.005574024,0.0060944613,0.009054232,0.000303796,0.0017623844],"genre_scores_gemma":[0.9027327,0.034011517,0.0027448623,0.023875108,0.00073705916,0.0093625905,0.0078037363,0.00047711367,0.018255332],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99672544,0.0005132979,0.0009650426,0.0009326289,0.00012336284,0.0007402029],"domain_scores_gemma":[0.99546695,0.000837313,0.0008556932,0.0022052436,0.00059219374,0.000042591695],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00038653731,0.00073017564,0.0010573986,0.0003789604,0.00080131606,0.000121629884,0.0015095004,0.0012910368,0.00018214602],"category_scores_gemma":[0.000030959356,0.00076969905,0.00040779356,0.00042852835,0.0010850277,0.00021588002,0.00068725424,0.0032373974,0.000023515497],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008864528,0.00013400364,0.0039683096,0.0018708883,0.00054397684,0.0000023362873,0.001679703,0.000035633675,0.4535181,0.0000023937255,0.5378422,0.0003138137],"study_design_scores_gemma":[0.0014392954,0.00008772276,0.000484798,0.00064295327,0.0018463008,0.000006650052,0.0005507957,0.001080797,0.48542184,0.000031522824,0.5077012,0.0007061495],"about_ca_topic_score_codex":0.0043281233,"about_ca_topic_score_gemma":0.00016329244,"teacher_disagreement_score":0.89145744,"about_ca_system_score_codex":0.00092501397,"about_ca_system_score_gemma":0.0010170043,"threshold_uncertainty_score":0.9994754},"labels":[],"label_agreement":null},{"id":"W4396900273","doi":"10.1002/cac2.12547","title":"Long‐term survival outcomes and immune checkpoint inhibitor retreatment in patients with advanced cervical cancer treated with camrelizumab plus apatinib in the phase II CLAP study","year":2024,"lang":"en","type":"article","venue":"Cancer Communications","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CAE (Canada)","funders":"","keywords":"Apatinib; Medicine; Oncology; Cervical cancer; Internal medicine; Overall survival; Cancer","score_opus":0.03813081594581162,"score_gpt":0.3588766162722905,"score_spread":0.32074580032647887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396900273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840896,0.009333777,0.0000035384453,0.003068133,0.000095031864,0.0027307908,0.00014532993,0.00006447482,0.00046929953],"genre_scores_gemma":[0.99497724,0.0014318097,0.00009628836,0.00014583611,0.00003610854,0.0028859377,0.0002238128,0.000045310306,0.00015768466],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980333,0.00021601579,0.0005322366,0.00044871794,0.00044099064,0.00032874485],"domain_scores_gemma":[0.99816227,0.00026888275,0.00010772634,0.001207592,0.0001298051,0.00012369556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017873768,0.00034146884,0.0006560108,0.00023169923,0.00021750614,0.000055187716,0.00034305398,0.00007399668,0.0001107618],"category_scores_gemma":[0.000028025834,0.0001855871,0.000071443355,0.0012801647,0.00019183854,0.0001528303,0.00019334434,0.00048791268,0.0000032359915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032554239,0.0051620724,0.94790834,0.00008874305,0.00047017014,0.000052395568,0.004286186,0.00001827894,0.000014305367,0.00003514921,0.000005482093,0.03870343],"study_design_scores_gemma":[0.04019564,0.0045691193,0.9526131,0.00072372827,0.00049172266,0.0000030365463,0.00088440266,0.000061838655,0.00006030144,0.0000087582575,0.00017177257,0.00021658633],"about_ca_topic_score_codex":0.005817081,"about_ca_topic_score_gemma":0.022528237,"teacher_disagreement_score":0.038486846,"about_ca_system_score_codex":0.001071275,"about_ca_system_score_gemma":0.00031678283,"threshold_uncertainty_score":0.9953081},"labels":[],"label_agreement":null},{"id":"W4402131379","doi":"10.1002/cac2.12604","title":"Perioperative toripalimab plus neoadjuvant chemotherapy might improve outcomes in resectable esophageal cancer: an interim analysis of a phase III randomized clinical trial","year":2024,"lang":"en","type":"article","venue":"Cancer Communications","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Engineering Link (Canada)","funders":"Wu Jieping Medical Foundation; National Natural Science Foundation of China","keywords":"Medicine; Interim analysis; Internal medicine; Clinical endpoint; Hazard ratio; Oncology; Chemotherapy; Neoadjuvant therapy; Perioperative; Esophageal cancer; Adverse effect; Randomized controlled trial; Cancer; Surgery; Confidence interval; Breast cancer","score_opus":0.10681879480942565,"score_gpt":0.512525384030229,"score_spread":0.4057065892208033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402131379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86090577,0.11868775,0.00044758237,0.011011787,0.00080087356,0.005706212,0.0009739501,0.00013506478,0.0013310052],"genre_scores_gemma":[0.97127026,0.021567212,0.0006356499,0.00027780322,0.00017338172,0.0037537327,0.00027690074,0.00003573415,0.0020093082],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99668366,0.0008780733,0.0012218186,0.00049666036,0.00036481218,0.00035496216],"domain_scores_gemma":[0.99669147,0.000906485,0.00019092043,0.0016822717,0.00026457396,0.00026426738],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014504818,0.00026259993,0.0020262725,0.000537236,0.0001282427,0.00007614869,0.0005706431,0.0001287326,0.00093156914],"category_scores_gemma":[0.00021648293,0.00019114911,0.0007337198,0.0012428389,0.0005705518,0.00021541383,0.00016576068,0.0006228066,0.0000043245645],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8288866,0.006155162,0.0072876927,0.0001904086,0.020034835,0.000120687255,0.015048864,0.00011865369,0.00095526996,0.0025031532,0.00027053786,0.118428126],"study_design_scores_gemma":[0.9056875,0.002442019,0.0016812801,0.00027981625,0.0036437411,0.0000017733518,0.0005761709,0.08266385,0.0011170066,0.000064137195,0.0015980427,0.0002446672],"about_ca_topic_score_codex":0.0136622,"about_ca_topic_score_gemma":0.011634156,"teacher_disagreement_score":0.118183464,"about_ca_system_score_codex":0.0010448447,"about_ca_system_score_gemma":0.0017295907,"threshold_uncertainty_score":0.9999817},"labels":[],"label_agreement":null},{"id":"W4404133614","doi":"10.1002/cac2.12624","title":"FOXO1 or not FOXO1: that is the question","year":2024,"lang":"en","type":"article","venue":"Cancer Communications","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Nautical Research Society","funders":"Ligue Contre le Cancer; Bristol-Myers Squibb","keywords":"FOXO1; Cytotoxic T cell; Granzyme B; Biology; Cell biology; Transcription factor; Cancer research; Chemistry; In vitro; Biochemistry; Gene","score_opus":0.20355240978209913,"score_gpt":0.4773397007046023,"score_spread":0.2737872909225032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404133614","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021978255,0.07610897,0.0011102865,0.77606374,0.00095876865,0.0024869505,0.0002064698,0.0007390058,0.12034752],"genre_scores_gemma":[0.8744871,0.028224535,0.00059608533,0.0045870654,0.0002628853,0.00068489125,0.00004972994,0.000046016896,0.09106169],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99912775,0.00012800841,0.00014219244,0.00016488483,0.00025644086,0.0001807106],"domain_scores_gemma":[0.9971877,0.00049247255,0.00002371722,0.0021126205,0.00010838927,0.000075133394],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035038608,0.00009369826,0.00012467912,0.00007918862,0.00025586656,0.00008792768,0.0006015767,0.000059940514,0.0061646462],"category_scores_gemma":[0.000058470207,0.000057984238,0.00009655617,0.00042466383,0.0002498872,0.000081361235,0.00022356746,0.0004927338,0.00023908878],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049716816,0.0002121412,0.0019825047,0.00028724468,0.0007048007,0.000017470475,0.00867568,0.000007761113,0.051258076,0.024973443,0.21477132,0.6966124],"study_design_scores_gemma":[0.00026106767,0.000056296758,0.0028598022,0.0002881256,0.000112990056,0.00002757193,0.00029226922,0.0028105574,0.0055659916,0.00044052428,0.9872038,0.00008101641],"about_ca_topic_score_codex":0.0007038311,"about_ca_topic_score_gemma":0.00080497854,"teacher_disagreement_score":0.85250884,"about_ca_system_score_codex":0.0002604993,"about_ca_system_score_gemma":0.00041608166,"threshold_uncertainty_score":0.9947438},"labels":[],"label_agreement":null},{"id":"W4404666579","doi":"10.1002/cac2.12632","title":"PTPN9 regulates HER3 phosphorylation during trastuzumab treatment and loss of PTPN9 is a potential biomarker for trastuzumab resistance in HER2 positive breast cancer","year":2024,"lang":"en","type":"letter","venue":"Cancer Communications","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Breakthrough Breast Cancer","keywords":"Trastuzumab; Breast cancer; Biomarker; Oncology; Internal medicine; Acquired resistance; Medicine; Cancer; Cancer research; Chemistry; Biochemistry","score_opus":0.015404052190529273,"score_gpt":0.2892659662646147,"score_spread":0.27386191407408544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404666579","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09357148,0.5368848,0.00022573056,0.32490492,0.00034373364,0.003307936,0.040541895,0.00005415133,0.00016538106],"genre_scores_gemma":[0.94199884,0.036809225,0.0013002806,0.007654944,0.0005751747,0.003612051,0.0052270335,0.00017540477,0.0026470262],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99824744,0.00011084774,0.00050128106,0.00065263314,0.0001393979,0.00034837195],"domain_scores_gemma":[0.9981052,0.000045652952,0.00029736783,0.0012887988,0.00021155308,0.000051391824],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000084289946,0.00041130988,0.00043988088,0.00013027752,0.0001762029,0.000053797907,0.0005320709,0.00045839677,0.000033816705],"category_scores_gemma":[0.00001331084,0.00041737716,0.00019632993,0.00022076014,0.00037858583,0.000016138774,0.00025146242,0.0003051502,0.0000011842822],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005283199,0.0013226733,0.004186965,0.0061281114,0.0059660943,0.000101257705,0.0044640996,0.00024536255,0.23441537,0.0007343334,0.70442355,0.032729007],"study_design_scores_gemma":[0.006045884,0.0005102954,0.051146597,0.0043310556,0.0016151468,0.00010525803,0.00023511924,0.0004123574,0.54128796,0.0014649439,0.39065942,0.0021859503],"about_ca_topic_score_codex":0.0018431288,"about_ca_topic_score_gemma":0.0026147966,"teacher_disagreement_score":0.84842736,"about_ca_system_score_codex":0.0005006909,"about_ca_system_score_gemma":0.00040567393,"threshold_uncertainty_score":0.9998278},"labels":[],"label_agreement":null},{"id":"W4406030350","doi":"10.1002/cac2.12650","title":"A strong internal promoter drives massive expression of YEATS‐domain devoid <i>MLLT3</i> transcripts in HSC and most lethal AML","year":2025,"lang":"en","type":"article","venue":"Cancer Communications","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Institut National Du Cancer; Association Laurette Fugain; Ministère de la Santé; Fondation ARC pour la Recherche sur le Cancer; Fondation de France; Institut National de la Santé et de la Recherche Médicale; Agence Nationale de la Recherche","keywords":"RNA polymerase II; Transcription factor; Transactivation; Molecular biology; Cell biology; Transcription (linguistics); Biology; Chemistry; Promoter; Gene expression; Genetics; Gene","score_opus":0.03057785634176597,"score_gpt":0.3543113829083722,"score_spread":0.32373352656660626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406030350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9560666,0.006142591,0.0022213697,0.017513907,0.00006703017,0.0009132651,0.0000811684,0.0000326674,0.016961414],"genre_scores_gemma":[0.9914172,0.00147171,0.005630355,0.00022228724,0.000019610836,0.0002486758,0.000034290686,0.00001470802,0.0009411442],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99899703,0.00017008524,0.00029819974,0.00019108722,0.00014708625,0.00019648089],"domain_scores_gemma":[0.99866045,0.0001481513,0.00006766067,0.00092127535,0.0001256058,0.000076862634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016854868,0.000113647344,0.0002570255,0.00021515122,0.000086518725,0.000015293126,0.00047429395,0.00008667965,0.00005867145],"category_scores_gemma":[0.000067254725,0.0001025568,0.00004449436,0.0003442646,0.0004036433,0.00010295405,0.00033522132,0.0005334118,0.0000017752487],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060321816,0.0005168442,0.09641122,0.00048700592,0.0001868069,0.000024130766,0.011162404,0.00002388868,0.8568508,0.004388277,0.0057099685,0.023635412],"study_design_scores_gemma":[0.026248246,0.00079158467,0.39270094,0.015267504,0.00045089587,0.000084369975,0.019746585,0.008255318,0.4384224,0.004993828,0.09201188,0.0010264339],"about_ca_topic_score_codex":0.00061599567,"about_ca_topic_score_gemma":0.0007407632,"teacher_disagreement_score":0.41842842,"about_ca_system_score_codex":0.0003017428,"about_ca_system_score_gemma":0.000482024,"threshold_uncertainty_score":0.4182145},"labels":[],"label_agreement":null},{"id":"W4406471500","doi":"10.1002/cac2.12661","title":"Bioequivalence of alternative pembrolizumab dosing regimens: current practice and future perspectives","year":2025,"lang":"en","type":"article","venue":"Cancer Communications","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bioequivalence; Dosing; Pembrolizumab; Medicine; Medical physics; Psychology; Pharmacology; Internal medicine; Pharmacokinetics; Cancer; Immunotherapy","score_opus":0.03932492012326258,"score_gpt":0.4011608327392284,"score_spread":0.3618359126159658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406471500","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.035119332,0.86458033,0.00035926537,0.07968725,0.00043397053,0.00060817105,0.00005077178,0.000050855084,0.019110076],"genre_scores_gemma":[0.6054515,0.3918733,0.0018873132,0.00040034892,0.00009332086,0.00007604025,0.0000075377493,0.0000075710936,0.00020303823],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993739,0.00008820642,0.00018853683,0.00015493075,0.00009937794,0.000095022806],"domain_scores_gemma":[0.9985255,0.00017797212,0.00014558915,0.0008131248,0.00030761518,0.000030210615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012946958,0.00008836461,0.00016354775,0.00008577974,0.0001453744,0.000014107958,0.00023119086,0.00003520553,0.000034158827],"category_scores_gemma":[0.000065627806,0.000079596255,0.0000541363,0.00033717032,0.00042178415,0.00012443327,0.0001283166,0.00020236317,6.2709915e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004446347,0.0013200148,0.0047049453,0.00069740735,0.0017014795,0.000002480319,0.029928235,0.0000043242308,0.0251926,0.10181245,0.00856057,0.82162917],"study_design_scores_gemma":[0.0037413568,0.00015434572,0.01721484,0.0013653818,0.00050742476,0.000023815064,0.019394297,0.00034408056,0.0029469486,0.00051980803,0.9536049,0.00018281299],"about_ca_topic_score_codex":0.0003662595,"about_ca_topic_score_gemma":0.000035929384,"teacher_disagreement_score":0.94504434,"about_ca_system_score_codex":0.00018456626,"about_ca_system_score_gemma":0.00026598808,"threshold_uncertainty_score":0.3245841},"labels":[],"label_agreement":null},{"id":"W4410905923","doi":"10.1002/cac2.70036","title":"Simvastatin overcomes the pPCK1‐pLDHA‐SPRINGlac axis‐mediated ferroptosis and chemo‐immunotherapy resistance in AKT‐hyperactivated intrahepatic cholangiocarcinoma","year":2025,"lang":"en","type":"article","venue":"Cancer Communications","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"China Postdoctoral Science Foundation; National Natural Science Foundation of China","keywords":"Protein kinase B; Cancer research; PI3K/AKT/mTOR pathway; Gemcitabine; Cancer; Medicine; Biology; Internal medicine; Phosphorylation; Signal transduction; Cell biology","score_opus":0.026813059557603505,"score_gpt":0.3202265771922991,"score_spread":0.2934135176346956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410905923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8979877,0.042075545,0.00004773978,0.052197225,0.00011298578,0.0009187525,0.00003849025,0.00009860248,0.0065229256],"genre_scores_gemma":[0.973454,0.020852013,0.0009804957,0.0029063127,0.000026904843,0.00093841663,0.000050586284,0.000032045737,0.0007592511],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99855334,0.00019287567,0.0004532344,0.00031288495,0.00018625591,0.0003014346],"domain_scores_gemma":[0.99743426,0.0005653397,0.0001393832,0.0016217727,0.00016709766,0.000072150666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027577215,0.00022685812,0.00040604363,0.00019277108,0.00033119405,0.00006912209,0.00057623634,0.000104734114,0.00013129014],"category_scores_gemma":[0.00017199574,0.00017890708,0.00008996687,0.0010993885,0.0004336991,0.00013394721,0.00020991697,0.00054952333,0.0000073386213],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000814097,0.0009282333,0.9053975,0.00041514562,0.00081133295,0.0000051870875,0.007534237,0.000022603292,0.020853208,0.008131073,0.007013897,0.048073526],"study_design_scores_gemma":[0.0030399538,0.000062678206,0.90280926,0.0009732897,0.00015959196,0.0000026051275,0.0016355417,0.0010375881,0.0035780817,0.00035981208,0.08603715,0.0003044591],"about_ca_topic_score_codex":0.0015776654,"about_ca_topic_score_gemma":0.0030155296,"teacher_disagreement_score":0.07902325,"about_ca_system_score_codex":0.00038040552,"about_ca_system_score_gemma":0.0003064304,"threshold_uncertainty_score":0.72956187},"labels":[],"label_agreement":null},{"id":"W4413942153","doi":"10.1002/cac2.70058","title":"Neoadjuvant chemoradiotherapy with capecitabine and irinotecan guided by <i>UGT1A1</i> status in patients with locally advanced rectal cancer: 5‐year update of the CinClare trial","year":2025,"lang":"en","type":"article","venue":"Cancer Communications","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CAE (Canada)","funders":"Key Research and Development Program of Zhejiang Province; National Health Commission of the People's Republic of China; National Natural Science Foundation of China","keywords":"Capecitabine; Irinotecan; Colorectal cancer; Medicine; Oncology; Internal medicine; Chemoradiotherapy; Neoadjuvant therapy; Cancer","score_opus":0.009827375372114715,"score_gpt":0.29053532309810265,"score_spread":0.28070794772598795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413942153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.974811,0.013804137,0.00002087463,0.007468494,0.000084263316,0.0019225257,0.00027492995,0.000022490747,0.0015912642],"genre_scores_gemma":[0.9872999,0.0102707455,0.00067563297,0.0005836362,0.000012779475,0.00078609464,0.000051200586,0.000020107402,0.00029989582],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99905,0.000056077955,0.00027683697,0.00022441556,0.0001823054,0.00021035051],"domain_scores_gemma":[0.9986478,0.000048624006,0.0001479131,0.0008602094,0.00023946744,0.000055962028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000049210754,0.00017491986,0.0004262825,0.000059636186,0.00017218606,0.000010944559,0.00023750788,0.000042937536,0.000029006298],"category_scores_gemma":[0.000017682834,0.00010643644,0.000036905465,0.0005130229,0.00034356053,0.000057557616,0.000136487,0.00020237833,1.476154e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0354596,0.0010466834,0.85082555,0.00010387616,0.0006542874,9.474899e-7,0.0011453497,0.00008792421,0.00033130817,0.00016283133,0.0026085253,0.1075731],"study_design_scores_gemma":[0.1633588,0.0024145648,0.77994215,0.0014858905,0.00042654338,0.000001173375,0.0004944918,0.000113695445,0.001552081,0.000038960752,0.049819354,0.0003523166],"about_ca_topic_score_codex":0.0026960182,"about_ca_topic_score_gemma":0.010992345,"teacher_disagreement_score":0.12789918,"about_ca_system_score_codex":0.00048127372,"about_ca_system_score_gemma":0.00051408546,"threshold_uncertainty_score":0.6133987},"labels":[],"label_agreement":null}]}